CL
CLVT.US CLARIVATE PLC
- Market cap
- USD 1.49B
- P/E
- -
- P/B
- 0.33x
- ROE
- -11.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CLVT.US undervalued?
Graham numberThe Graham number of CLARIVATE PLC cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CLARIVATE PLC fundamental analysis
No fundamental analysis for CLARIVATE PLC yet.
CLARIVATE PLC stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CLARIVATE PLC
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, book…
Full company profileCLARIVATE PLC financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CLARIVATE PLC annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 514M | 918M | 968M | 974M | 1.25B | 1.88B | 2.66B | 2.63B | 2.56B | 2.46B | 2.21B |
| Gross Profit | 168M | 523M | 572M | 622M | 855M | 1.25B | 1.71B | 1.72B | 1.69B | 1.62B | 1.52B |
| Operating Income | 24.5M | -147M | -106M | -82.5M | 52.4M | -87.0M | -3.93B | -735M | -276M | 71.5M | -173M |
| EBITDA | - | 162M | 132M | 110M | 197M | 532M | 1.30B | -10.5M | 457M | 929M | 535M |
| Net Income | 13.8M | -264M | -242M | -259M | -106M | -271M | -3.96B | -911M | -637M | -201M | -519M |
| EPS | 0.06 | -0.86 | -0.79 | -0.94 | -0.39 | -0.42 | -5.84 | -1.36 | -0.92 | -0.30 | -0.81 |
| Balance Sheet | |||||||||||
| Total Assets | 775M | 4.01B | 3.71B | 3.79B | 15.2B | 20.2B | 13.9B | 12.7B | 11.5B | 11.1B | 10.4B |
| Total Liabilities | 394M | 2.72B | 2.66B | 2.54B | 5.60B | 8.26B | 7.13B | 6.71B | 6.35B | 6.23B | 5.85B |
| Shareholders' Equity | 381M | 1.29B | 1.05B | 1.25B | 9.59B | 11.9B | 6.81B | 5.99B | 5.14B | 4.84B | 4.51B |
| Cash & Short-term Investments | 38.0M | 53.2M | 25.6M | 76.1M | 258M | 588M | 349M | 371M | 295M | 329M | 257M |
| Total Debt | - | 2.01B | 1.99B | 1.72B | 3.49B | 5.61B | 5.10B | 4.81B | 4.59B | 4.48B | 4.18B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 69.0M | 6.67M | -26.1M | 118M | 324M | 509M | 509M | 744M | 647M | 629M | 532M |
| Capital Expenditure | 31.9M | 37.8M | 45.4M | 69.8M | 119M | 203M | 203M | 243M | 289M | 263M | 221M |
| Free Cash Flow | - | -31.1M | -71.5M | 47.7M | 205M | 306M | 306M | 502M | 358M | 365M | 311M |
| Ratios | |||||||||||
| ROE | 3.6% | -20.5% | -23.0% | -20.7% | -1.1% | -2.3% | -58.1% | -15.2% | -12.4% | -4.2% | -11.5% |
| ROA | 1.8% | -6.6% | -6.5% | -6.8% | -0.7% | -1.3% | -28.4% | -7.2% | -5.5% | -1.8% | -5.0% |
| Net Profit Margin | 2.7% | -28.8% | -25.0% | -26.5% | -8.5% | -14.4% | -148.9% | -34.7% | -24.9% | -8.2% | -23.5% |
| Debt to Equity | - | 1.57x | 1.89x | 1.38x | 0.36x | 0.47x | 0.75x | 0.80x | 0.89x | 0.92x | 0.93x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CLARIVATE PLC dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | USD 37.7M | 0.05 | - |
| 2023 | USD 75.5M | 0.11 | - |
| 2022 | USD 75.4M | 0.11 | - |
| 2021 | USD 75.4M | 0.12 | - |
| 2020 | USD 18.9M | 0.07 | - |
| 2019 | USD 18.9M | 0.07 | - |
| 2018 | USD 18.9M | 0.06 | - |
| 2017 | USD 10.2M | 0.03 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jun 4, 1991.
Who owns CLARIVATE PLC
- Insiders 18.32%
- Institutions 81.68%
- Public & others 0.00%
- Shares outstanding 640M
- Free float 469M
Top funds holding CLVT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Avantis US Small Cap Value ETF | 16.0M | 2.51% | +0.44% | Oct 2026 |
| Clarkston Partners Founders | 12.0M | 1.88% | +2.13% | Sep 2026 |
| Fidelity Intl Equity Private Pl Cl S5 | 10.8M | 1.69% | 0.00% | Jun 2026 |
| EdRF Big Data N EUR | 9.24M | 1.44% | -1.49% | Sep 2026 |
| iShares Russell 2000 ETF | 8.92M | 1.39% | 0.00% | Oct 2026 |
| DFA U.S. Small Cap Value I | 7.40M | 1.16% | +30.77% | Sep 2026 |
| Invenomic Institutional | 5.61M | 0.88% | +5.43% | Jul 2026 |
| Fidelity Small Cap Index | 3.93M | 0.61% | +2.53% | Aug 2026 |
| Fidelity Global Concentrated Eq Cl F | 3.69M | 0.58% | 0.00% | Jun 2026 |
| Clarkston Founders Institutional | 3.55M | 0.55% | 0.00% | Sep 2026 |
| iShares Russell 2000 Value ETF | 3.28M | 0.51% | 0.00% | Oct 2026 |
| Jupiter Merian Glb Eq Abs Rt I USD Acc | 3.13M | 0.49% | 0.00% | Jun 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 2.40M | 0.38% | 0.00% | Oct 2026 |
| Schwab Fundamental U.S. Small CompanyETF | 2.38M | 0.37% | 0.00% | Oct 2026 |
| DFA U.S. Targeted Value I | 2.27M | 0.36% | 0.00% | Sep 2026 |
| Transamerica Mid Cap Value Opps I3 | 2.23M | 0.35% | 0.00% | Sep 2026 |
| Dimensional US Small Cap Value ETF | 2.21M | 0.35% | 0.00% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 2.07M | 0.32% | +0.24% | Oct 2026 |
| Vanguard Russell 2000 ETF | 2.04M | 0.32% | +1.36% | Sep 2026 |
| Fidelity Extended Market Index | 1.82M | 0.29% | +125.21% | Sep 2026 |
Top institutions holding CLVT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| LEONARD GREEN PARTNERS LP | 117M | 18.23% | 0.00% | Jun 2026 |
| EXOR NV | 67.3M | 10.52% | 0.00% | Jun 2026 |
| Clarkston Capital Partners, LLC | 45.7M | 7.15% | +6.74% | Jun 2026 |
| BlackRock Inc | 31.2M | 4.87% | +47.89% | Jun 2026 |
| Partners Group Holding AG Junk | 25.6M | 4.00% | 0.00% | Jun 2026 |
| Fidelity International Ltd | 25.3M | 3.95% | 0.00% | Jun 2026 |
| Edmond de Rothschild Holding S.A. | 16.2M | 2.53% | -8.98% | Jun 2026 |
| Citadel Advisors Llc | 14.6M | 2.29% | -17.31% | Jun 2026 |
| American Century Companies Inc | 14.3M | 2.23% | +14.79% | Jun 2026 |
| Invenomic Capital Management, LP | 14.3M | 2.23% | +7.15% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 13.9M | 2.17% | -27.15% | Sep 2026 |
| First Trust Advisors L.P. | 13.5M | 2.12% | +145.12% | Jun 2026 |
| Atairos Group, Inc | 12.3M | 1.92% | 0.00% | Jun 2026 |
| Thompson, Siegel & Walmsley LLC | 12.2M | 1.90% | +11.49% | Sep 2026 |
| State Street Corp | 10.9M | 1.70% | +45.21% | Jun 2026 |
| Geode Capital Management, LLC | 10.1M | 1.57% | +43.21% | Jun 2026 |
| AustralianSuper Pty Ltd | 10.1M | 1.57% | 0.00% | Jun 2026 |
| BW Gestao de Investimentos Ltda | 10.0M | 1.57% | +69.54% | Jun 2026 |
| Prudential Financial Inc | 8.06M | 1.26% | -26.33% | Jun 2026 |
| AQR Capital Management LLC | 6.92M | 1.08% | +130.97% | Jun 2026 |
CLARIVATE PLC company profile
- Company name
- CLARIVATE PLC
- Ticker
- CLVT.US
- ISIN
- JE00BJJN4441
- Exchange
- USA Stocks
- Listed since
- Oct 29, 2018
- Sector
- Technology
- Industry
- Professional Services
- Employees
- 12,000
- Fiscal year end
- December
- Address
- 70 St. Mary Axe, London, United Kingdom, EC3A 8BE
- Phone
- 44 20 7433 4000
- Website
- clarivate.com
About CLARIVATE PLC
Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
CLARIVATE PLC management
10- Mr. Matitiahu Shem TovCEO & Director · born 1961
- Mr. Bar VeinsteinPresident of Academia & Government · born 1973
- Mr. Michael EastonExecutive VP & CFO · born 1973
- Mr. Matthew LisowskiSenior VP & Chief Accounting Officer · born 1986
- Mr. William E. GraffExecutive VP & Chief Information Officer
- Mr. Mark J. Donohue CPAHead of Investor Relations
- Mr. John DoulamisSenior VP & General Counsel
- Ms. Gwenan WhiteSenior Vice President of Communications & Brand
- Ms. Darien KrimmertSenior VP & Head of People
- Mr. Richard C. FinchSenior Vice President of Life Sciences and Healthcare